Although the previous study successfully demonstrated the generation of iNSCs which could be readily differentiated into DA neurons using a total of nine factors including Lmx1a, it is hard to conclude which cell line is the better cell source for treating PD because we have not compared both cell types side-by-side. The gene discussed is LMX1A; the disease is Parkinson disease.